Jennifer A. Yoon advises clients across the life sciences industry on complex corporate and securities law matters.
Jennifer combines extensive transactional experience and a client-first approach to guide biotechnology and other life sciences companies at every stage of maturity through:
She keenly understands the capital markets implications for life sciences companies and distills complex scientific and legal jargon into actionable client advice. Jennifer develops trusted, long-term relationships to both help clients navigate high-stakes transactions and strategize solutions to day-to-day corporate issues that arise.
A recognized leader at the firm, Jennifer serves on the Ethics Committee and previously served on the Associates Committee.
Before her legal career, Jennifer was a children’s book editor.
Jennifer's experience includes advising on:
Jennifer's experience representing US and international public companies in their securities law compliance and other public company matters includes advising:
Jennifer's experience representing early-stage companies in their preferred equity financings and on corporate governance strategy includes advising:
Firm’s Capital Markets Practice once again earns top legal advisor league table rankings across debt and equity products and industries globally in Bloomberg, Dealogic, Deal Point Data, and LSEG.
Firm honored for steering record-breaking and innovative transactions and general excellence.